MADELYN ALMONTE: Open Payments
NPI 1518373059 · LAGRANGE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$924 in 49 payments from 19 companies in 2025. Trend: 2023 $1,242 · 2024 $1,306 · 2025 $924
Food & beverage: $924
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 7 | $149 |
| Novartis Pharmaceuticals Corporation | 5 | $108 |
| PFIZER INC. | 6 | $102 |
| Daiichi Sankyo Inc. | 4 | $73 |
| PharmaEssentia USA Corporation | 4 | $70 |
| AstraZeneca Pharmaceuticals LP | 3 | $51 |
| ABBVIE INC. | 2 | $48 |
| Stemline Therapeutics Inc. | 2 | $46 |
| SOBI, INC | 2 | $37 |
| Incyte Corporation | 2 | $37 |
Products named: KEYTRUDA, KISQALI, Enhertu, BESREMI, XTANDI, LYNPARZA, EPKINLY, Orserdu.
Industry payments across GA — which companies pay providers there.
